Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 17291 - 17300 of 24215
| Identification Number | Trade Name | Benefit Category |
|---|---|---|
| 02406705 | CYTARABINE PWS 1G/VIAL | Standard Benefit for Eligible Clients |
| 02406713 | CYTARABINE PWS 2GM/VIAL | Standard Benefit for Eligible Clients |
| 02406764 | PMS-CYTARABINE INJ LIQ 20MG/ML | Standard Benefit for Eligible Clients |
| 02406772 | PMS-CYTARABINE INJ 100MG/ML LIQ IV | Standard Benefit for Eligible Clients |
| 02406810 | TARO-IRBESARTAN TAB 75MG | Standard Benefit for Eligible Clients |
| 02406829 | TARO-IRBESARTAN TAB 150MG | Standard Benefit for Eligible Clients |
| 02406837 | TARO-IRBESARTAN TAB 300MG | Standard Benefit for Eligible Clients |
| 02406853 | FONDAPARINUX SODIUM INJ 2.5MG/.5ML | Standard Benefit for Eligible Clients |
| 02406861 | SANDOZ-CARBAMAZEPINE TAB 200MG | Standard Benefit for Eligible Clients |
| 02406896 | FONDAPARINUX SODIUM INJ 12.5MG/ML | Standard Benefit for Eligible Clients |
Displaying 17291 - 17300 of 24215